About American West Side Story Financial Group Inc

About American probes west side story musical Financial Group, west side sory observes Inc.American Financial Group is an insurance holding company, based in Cincinnati,Ohio with assets in excess of $25 billion West Side Story tickets – wikipedia . Through the operations of GreatAmerican Insurance Group, AFG is engaged primarily in property and casualtyinsurance, focusing on specialized commercial products for businesses, and inthe sale of traditional fixed, indexed and variable annuities and a variety ofsupplemental insurance products. Great American Insurance Group`s roots go backto 1872 with the founding of its flagship company, Great American InsuranceCompany. Certain statements may be made on the conference call that may be considered”forward-looking statements” within the meaning of Section 27A of the SecuritiesAct of 1933 and Section 21E of the Securities Exchange Act of 1934 West Side Story tickets .Actualresults could differ materially from any predictions that may be made.Additionalinformation regarding factors that could cause such differences appears in thepress release.American Financial Group, Inc.Investor Relations, Copyright Business Wire 2009. CAMBRIDGE, Mass.–(Business Wire)–Dyax Corp (NASDAQ:DYAX) announced today that the U.S. Food and DrugAdministration`s (FDA) Pulmonary-Allergy Drugs Advisory Committee is scheduledto discuss the Company`s Biologics License Application (BLA) for DX-88(ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE)on February 4, 2009.

An advisory committee is a group of experts that providesthe FDA with advice and is convened by the FDA as part of its review of a noveltherapy west side story music . If DX-88 receives FDA approval, it would become the first product to beindicated for the treatment of acute attacks of HAE in the U.S west side storry . Dyax submittedits BLA for DX-88 on September 23, 2008, and was designated for Priority Reviewupon FDA acceptance of the application westside story 1961 West Side Story tickets – westsidestory . With Priority Review designation, whichis intended for those products that address unmet medical needs, DX-88`sPrescription Drug User Fee Act (PDUFA) target action date is March 23, 2009 somewhere westside story . “With no treatment approved for acute attacks of HAE in the U.S., a new therapyfor this debilitating and life-threatening disease remains a priority,”commented Gustav A. Christensen, President and Chief Executive Officer of Dyax.”DX-88 meets a number of criteria cited as important by both patients andphysicians and was tested in a Phase 3 clinical program representing the largestplacebo-controlled evaluation of any drug developed to treat this disease.

Welook forward to presenting the results of these trials and other data from ourcomprehensive HAE program to the committee and continuing to advance the BLA forDX-88.” The BLA submission was based primarily on data from two placebo-controlled Phase3 clinical trials, known as the EDEMA3 and EDEMA4 songs west side story . In those trials, DX-88demonstrated statistically significant improvements over placebo in both theprimary and secondary endpoints and was found to be well tolerated tonight westside story West Side Story tickets . About DX-88 for HAEThe recombinant, small protein, DX-88 (ecallantide), was discovered utilizingDyax`s proprietary phage display technology westside story tony . DX-88 is a potent and selectiveplasma kallikrein inhibitor, a key mediator of inflammation in angioedema, andis being evaluated as a subcutaneous therapy for treating acute HAE attacks westside story anita . About HAEHereditary Angioedema (HAE) is an acute inflammatory condition characterized byepisodes of severe, often painful swelling affecting the extremities, thegastrointestinal tract, the genitalia, and in potentially life-threateningcases, the larynx. HAE is caused by low or dysfunctional levels of C1 esteraseinhibitor (C1-INH), a naturally occurring molecule that inhibits plasmakallikrein, a key mediator of inflammation, and other serine proteases in theblood.

About DyaxDyax is focused on advancing novel biotherapeutics for unmet medical needs, withan emphasis on oncology and inflammatory indications broadway west side story . Dyax utilizes itsproprietary drug discovery technology to identify antibody, small protein andpeptide compounds for clinical development westside story jets . Dyax`s lead product candidate isDX-88 (ecallantide), a recombinant small protein that is currently beingevaluated for its therapeutic potential in two separate indications On November21, 2008, the U.S westside story sharks . Food and Drug Administration (FDA) accepted for filing theCompany`s Biologics License Application for approval of DX-88 for the treatmentof hereditary angioedema (HAE) and designated the application for PriorityReview west side maria . Based on this designation, the FDA Prescription Drug User Fee Act(PDUFA) target action date is March 23, 2009 DX-88 has orphan drug designationin the U.S. and E.U., as well as Fast Track designation in the U.S., for thetreatment of acute attacks of HAE.

Additionally, DX-88 is being evaluated forthe prevention of blood loss during on-pump cardiothoracic surgery (CTS) throughits partner, Cubist Pharmaceuticals . Dyax licensed to Cubist the intravenousformulation of DX-88 for surgical indications in North America and Europe westside story poster West Side Story tickets – wikipedia . DX-88and other compounds in Dyax`s pipeline were identified using its patented phagedisplay technology, which rapidly selects compounds that bind with high affinityand specificity to therapeutic targets bernstein westside story West Side Story tickets . Dyax leverages this technology broadlywith over 70 revenue generating licenses and collaborations for therapeuticdiscovery, as well as in non-core areas such as affinity separations, diagnosticimaging, and research reagents Dyax is headquartered in Cambridge,Massachusetts .

Freudenberg remained the number one player, although poor economic conditionshave forced the company to close operations serving the automotive market andimprove efficiencies at others. The Vikings were loaded with talent on the offensive line and had the most explosive young player in the game in Adrian Peterson. Senior WR Seyi Ajirotutu (6-3, 210) leads a strong receiving corps after compiling 795 yards in receiving. There was a game recently where we had the bases loaded three times and three different hitters came up and we did not get a single run That is almost impossible. It would be about his only significant contribution in the NFL but the record still stands today. This article is also featured on GridironFans .